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Abstract Milk nutrients are secreted by epithelial cells in the
alveoli of the mammary gland by several complex and highly
coordinated systems. Many of these nutrients are transported
from the blood to the milk via transcellular pathways that
involve the concerted activity of transport proteins on the apical
and basolateral membranes of mammary epithelial cells. In this
review, we focus on transport mechanisms that contribute to the
secretion of calcium, trace minerals and water soluble vitamins
into milk with particular focus on the role of transporters of the
SLC series as well as calcium transport proteins (ion channels
and pumps). Numerous members of the SLC family are in-
volved in the regulation of essential nutrients in the milk, such
as the divalent metal transporter-1 (SLC11A2), ferroportin-1
(SLC40A1) and the copper transporter CTR1 (SLC31A1). A
deeper understanding of the physiology and pathophysiology
of these transporters will be of great value for drug discovery
and treatment of breast diseases.
Keywords SLC transporters . ABC transporters . Calcium
transporters and breast cancer
Abbreviations
ABC ATP-binding cassette
BCRP Breast cancer resistance protein
CP Ceruloplasmin
CTR Copper transporter
Dcytb Duodenal cytochrome b
DMT1 Divalent metal-ion transporter 1
ER Endoplasmic reticulum
FPN Ferroportin-1
HEP Hepcidin
IRE Iron-responsive element
IRP Iron-regulatory proteins
MECs Mammary epithelial cells
MRP Multidrug resistance associated protein
PCFT Proton-coupled folate transporter
PMCA Plasma membrane Ca2+-ATPase
RFC Reduced folate carrier
RFVT Riboflavin transporters
SERCA Sarco(endo)plasmic reticulum Ca2+- ATPase
SLC Solute carrier
SMCT Sodium-coupled monocarboxylate
cotransporters
SMVT Sodium-coupled multivitamin transporter
SPCA Secretory pathway Ca2+-ATPase
STEAP Six-transmembrane epithelial antigen of the
prostate
SVCT Sodium-coupled vitamin C transporter
TfR Transferrin receptor-1
TRP Transient receptor potential
ZIP ZRT, IRT-like Protein
Introduction
The mammary gland is an exocrine organ which primary
functions to produce milk to nourish young offspring. Milk
is an emulsion of fat and an aqueous solution containing
sugars, proteins, minerals and vitamins. The alveoli are the
fundamental secretory units of the breast, composed of a
single layer of polarized epithelial cells which are surrounded
by contractile myoepithelial and adipose cells (Fig. 1). During
lactation, milk is produced and secreted into a central lumen of
the alveolus by a diverse set of transport mechanisms that
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occur both within and between alveolar epithelial cells
(Fig. 1). The alveoli are organized into lobules, each of which
drains into a ductal system which finally carries the secretion
products to the outside.
Epithelial Transport in the Mammary Gland
The composition of the milk reflects the orchestration of
many transport processes found in mammary epithelial
cells (MECs). Hence, understanding the mechanism un-
derlying mammary epithelial solute transport is essential
to understand the cell biology and physiology of milk
formation. To achieve transepithelial vectorial transport
of the milk components, MECs take advantage of their
asymmetrical properties (i.e. different but complementa-
ry transport proteins are expressed in the apical and
basolateral membranes). These polarized cells are joined
together by tight junctions that also act as a barrier
“fence” which helps maintain epithelium polarity.
These two functional structures (polarized cells and tight
junctions) provide mammary epithelium asymmetry and
as a consequence the capability of vectorial transport of
solutes.
There are two principle pathways by which solutes
can move across an epithelium, the paracellular and the
transcellular pathways. In the first pathway, the sub-
stances are transported across the epithelium by passing
through the tight junction and the lateral intercellular
spaces surrounding each epithelial cell. In contrast, the
transcellular pathway involves the transport of sub-
stances through the cell, passing through the apical
and basolateral membranes. Epithelia were divided by
Frömter and Diamond into two broad categories based
on the relative resistance of tight junction [1]. Leaky
epithelia have low resistance tight junctions (from 6 to
150 Ωcm2), whereas tight epithelia show high resistance
tight junctions (from 500 to 70,000 Ωcm2). The junc-
tional resistance has also consequences for other physi-
ological properties of epithelia. Tight epithelia can es-
tablish and maintain large electrolyte and non-electrolyte
gradients and they can generate high transepithelial
voltages. In contrast, leaky epithelia show lower
transepithelial voltage and they cannot maintain large
solute concentration gradients. In general, leaky epithe-
lia are very efficient in performing bulk transepithelial
transport of solutes and water in a nearly isosmotic
fashion. On the other hand, tight epithelia can generate
and maintain large transepithelial ion concentration or
osmotic gradients.
Lactogenesis comprises profound and rapid programmed
changes that transform the alveolar epithelium into a fully
secretory active tissue at parturition. The mammary epitheli-
um is leaky before lactation, allowing the passage of sub-
stances between epithelial cells. Shortly after parturition and
throughout lactation, there is a dramatic increase in milk
secretion in responses to a complex sequence of hormonal
stimuli. Tight junctions form a highly impermeable barrier
between the milk and interstitial fluid. During this phase, the
alveolar epithelium shows the characteristics of a tight epithe-
lium that allows the establishment and maintenance of a large
transepithelial concentration gradient for ions and macromol-
ecules. Moreover, the permeability of tight junctions is closely
Fig. 1 Schematic representation of an alveolus. The alveolus is the
fundamental secretory unit of breast tissue. Alveoli consist of a single
layer of polarized secretory epithelial cells (alveolar cells) surrounded by
contractile myoepithelial and adipose cells (not shown). The alveolar cells
are joined together by tight junctions. These polarized cells and the tight
junctions allow mammary epithelium to perform vectorial transport of
electrolytes and non-electrolytes into the milk. Two major pathways are
followed by solutes when moving across an epithelium, the paracellular
and the transcellular pathways. Paracellular pathway: the substances are
transported across an epithelium by passing through the tight junctions
and the lateral intercellular spaces surrounding each epithelial cell. Trans-
cellular pathway: substances are transported through the cell, passing
through both the apical membrane and basolateral membrane
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related to milk secretion. A decrease in tight junction perme-
ability is accompanied by an increase in the rate of milk
secretion and conversely, an increase in tight junction perme-
ability is accompanied by decrease in the milk secretion rate.
The roles of the epithelial tight junction and the paracellular
pathway in milk production are, however, beyond the scope of
this review. A review on tight junction function in the mamma-
ry gland can be found in the present issue by Stelwagen and
Singh as well as in previous contributions to this journal [2, 3].
The Transcellular Pathway in the Alveolar Epithelium
During lactation, the transcellular pathway is the main route
for transporting the milk nutrients, such as calcium, iron and
water soluble vitamins. This assumption is based on the low
permeability of the tight junction of alveolar epithelia during
lactation and the large concentration gradients of ions and
macromolecules existing between blood and milk. Four major
cellular routes are thought to be utilized by the mammary
epithelium to secrete the milk components:
1- Exocytotic pathway. Milk proteins synthesized in the
endoplasmic reticulum (ER), such as casein, are packaged
into Golgi-derived vesicles. Here alveolar cells add dif-
ferent nutrients, as calcium (see Calcium transport section
below), zinc, phosphate, lactose and citrate to the lumen
of the secretory vesicles. These secretory vesicles move to
the apical membrane where they secrete their content into
the milk space by exocytosis.
2- Lipid pathway. Lipids coalesce into cytoplasmic lipid
droplets and move to the apical membrane. These lipid
droplets are enveloped by the apical plasma membrane
and finally secreted from the cell as the milk fat globule.
3- Transcytosis pathway. The basolateral membrane takes
up proteins, such as immunoglobulins, by endocytosis.
These vesicles are transported across the cell to the apical
membrane where the cell secretes their contents into the
milk space by exocytosis.
4- Membrane transport pathways. Specific transporters locat-
ed at the basolateral membrane, Golgi apparatus, secretory
vesicles and apical membrane move electrolytes and non-
electrolytes from the interstitial fluid into the milk.
These cellular pathways were described in detail by
McManaman and Neville [4], and are also addressed in sev-
eral reviews of this issue (e.g. Ontsouka et al.).
Membrane Transport Pathways
In the following sections we discuss the transport mechanisms
involved in secretion of calcium and micronutrients, such as
iron, cooper and water soluble vitamins, into milk. In this
review we focus on the membrane transporters expressed
at the apical or basolateral membranes of MECs (i.e. transcel-
lular pathway) that may play a role in the delivery of essential
nutrients into the milk. Members of the SLC30 (zinc efflux
transporters) and SLC39 (zinc influx transporters) families
have been shown to be involved in the vectorial transport of
zinc trough the mammary secretory epithelium. The role of
these transporters in the regulation of milk zinc concentration
are not going to be covered here since they are reviewed by
McCormick et al. in this review series.
Calcium Transport in the Mammary Gland
Milk production requires the transport of large amounts of
calcium through the MECs. Humanmilk contains up to 5 mM
of total calcium after 90 h post-partum [5]. Mammary gland
calcium transport comprises a transcellular and overall unidi-
rectional flux [6] against the steep concentration gradient that
exists between the extracellular fluid and the milk operating
over an extended period of time (Fig. 2). This process mainly
involves (i) the uptake of calcium from the interstitial fluid
through the basolateral membrane of the MEC, (ii) its secre-
tion to the milk from the apical side, and (iii) the intraorganelle
storage and buffering of cytoplasmic calcium during its pas-
sage through the cell in order to avoid its cytotoxicity. Figure 2
shows a representation of the different transport mechanisms
that regulate the concentration of calcium in the milk.
Role of TRP Channels in Calcium Secretion The first event,
i.e. the calcium transport across the blood-facing membrane,
must operate with high capacity, given the large amount of
calcium secreted intomilk. Experimental findings showed that
this process is temperature dependent and induced during the
transition from pregnancy to lactation [7]. Calcium channels
(e.g. members of the transient receptor potential (TRP) family)
have been proposed to play a role in this process since their
kinetic characteristics make them likely candidates to contrib-
ute to transepithelial calcium transport. However, the exact
mechanism responsible for calcium transport across the
basolateral membrane of secretory MECs still remains largely
unknown [8]. Although some calcium channels have been
involved in mammary gland pathologies such as breast cancer
[9–11], the identification of the molecular entity(ies) involved
in calcium secretion to the milk is still missing. One class of
calcium channels compatible with the characteristics of
the calcium transport observed in MECs are the TRP
superfamily of cation channels, in particular TRPV5 and
TRPV6. These channels present high selectivity for calci-
um over monovalent cations and display constitutive ac-
tivity and saturable kinetics in the submillimolar range [12,
13]. TRPV5 has been found to be localized in apical mem-
branes in the kidney [14, 15] but not in the mammary gland,
whereas TRPV6 is found in the apical membranes of
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epithelial cells of the intestine and exocrine tissues [16].
Indeed, apical expression of TRPV6 has been shown in
normal human MEC [16] where it would mediate calcium
re-uptake from the luminal side.
Differential Expression of TRPV-6 During Pregnancy Lacta-
tion Cycle Given its apical localization, TRPV6 would be
expected to contribute to the re-uptake of calcium from the
milk rather than to the transport of calcium into themilk. Recent
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studies in our laboratories revealed significant downregulation
of bovine TRPV6 during lactation (Fig. 2b; unpublished data
obtained in collaboration with K. Sejrsen, Aarhus University,
Denmark). Figure 2b shows that the mRNA abundance of
bovine TRPV6 is greatest during the periods of reduced or
absent lactation, i.e. at the end of the previous lactation (d-77)
and during the dry period (d-48 and d-16) preceding the next
lactation cycle. In contrast, the gene expression of TRPV6 was
lowest during the first 2 weeks after parturition when the milk
yield starts to markedly increase in early lactation (d14 to 100).
The gene expression of TRPV6 remained unchanged through-
out early and mid-lactation (d100 to 200). The significantly
higher TRPV6 mRNA levels during the non-lactating states as
compared to lactation suggest a physiological mechanism par-
ticularly during the non-lactating states (i.e. before milk pro-
duction or during weaning) to prevent loss of excessive serum
calcium into the mammary alveoli through reabsorption via
TRPV6. On the other side, low TRPV6 levels during lacta-
tion may prevent reabsorption of calcium from the milk in
the lactating state when the calcium demand for the neonate
is high. In general, the apical localization of TRVP6, if
consistently confirmed, could suggest that the transporter
might play a role in calcium re-uptake from the alveolar
lumen. The process of calcium re-uptake during lactation
might contribute to maintain the necessary elevated milk
calcium content necessary for fulfilling nutritional require-
ments of the offspring. On the other hand, the re-uptake of
calcium through TRPV6 might also play an important role
especially during involution when milk production ceased
and the synthetic activity of the mammary gland is low.
Indeed, in non-lactating mammary tissues, it could be as-
sumed that calcium re-uptake contributes to reduce its lu-
minal content, and, therefore, the risk of calcification in the
mammary gland. This mechanism may play a role in the
prevention of breast lesions. However, additional investiga-
tions are needed to better understand the underlying path-
ways, including hormonal influences and regulatory fac-
tors, leading to the differential expression profile, and to
clearly define the physiological role of TRPV6 in the lac-
tating and non-lactating mammary gland.
Role of Stretch-Activated Calcium Channels Channel candi-
dates for calcium entry at the basolateral membrane are the
stretch-activated channels as MECs undergo extensive me-
chanical deformation upon filling and emptying of the alveoli.
Experimental evidence showed that hypo-osmotic stress gen-
erates an increase in the cytosolic calcium concentration in
lactating MECs, being the major contributor to the signal for
influx of extracellular calcium [17]. However, no molecular
entity has yet been found to be responsible for the observed
effect. Moreover, the mechanical effect seems to be more
complex than the simple direct activation of stretch-sensitive
channels, as demonstrated by Enomoto el al. [18]. These
investigators found not only that the mechanically stimulated
cultured mouse mammary cells showed an increase in the
intracellular calcium concentration but the response was also
extended to the non-touched surrounding cells, suggesting the
involvement of a paracrine factor [19, 20]. Along this line of
evidence, ATP is likely to be the mediator, as it has been found
to be released upon mechanical stimuli in cultured mammary
cells [20] and to trigger the influx of calcium from the extra-
cellular side by activating the P2-purinergic receptors [21].
However, in spite of all the experimental efforts made in this
field, as also shown by the genome-wide screen performed by
VanHouten & Wysolmerski [22], the identity of the putative
calcium channel responsible for calcium entry into MECs
remains elusive. Additionally, although the presence of P2-
purinergic receptors is well documented in breast cancer cell
lines [23], experimental data failed to show its presence in
preparations of primary acini in suspension freshly isolated from
mouse [17]. This can be explained by the fact that the phenotype
of a tumour cell line can differ considerably from that of primary
cells and, thus, the experimental model would not reflect pre-
cisely what occurs in the physiology of normal cells.
Exocytotic Pathway for Calcium Secretion Once in the MEC,
calcium secretion to the milk is traditionally accepted to occur
via exocytosis of secretory vesicles packaged within the Golgi
Fig. 2 Transcellular transport of calcium into the milk. a In the upper
panel, the calcium concentration gradients across the different cellular
membranes are represented with a red line. Since the calcium
concentration in the Golgi vesicles remains unknown, the gradient of
calcium between the cytosol and the milk across the apical membrane is
represented by a dashed line. The transport mechanisms that mediate
basolateral calcium uptake are not known. Calcium transport down its
electrochemical gradient across the basolateral membrane may be
mediated by a passive transport mechanism (e.g. calcium channels).
Calcium secretion to the milk is traditionally accepted to occur via
exocytosis of secretory vesicles packaged within the Golgi as calcium
phosphate, calcium citrate and calcium complexed with caseins, the latter
comprising the majority of the total calcium present in the milk. Once
inside the alveolar cell, calcium is pumped across Golgi vesicles by
SPCA, across the endoplasmic reticulum by SERCA (not shown), or is
sequestered by cytosolic calcium-binding proteins. Finally, calcium is
secreted into milk by exocytosis of the Golgi-derived vesicles at the
apical membrane. Alternatively, calcium can be pumped out of the cell
into the milk by PMCA2bw. The apical membrane does not display a
high permeability for calcium. TRPV6 has been shown to be expressed in
the apical membrane of human MECs, however its role in mammary
epithelial calcium transport remains largely unknown. b TRPV6 mRNA
expression during the pregnancy-lactation cycle. TRPV6 mRNA
abundance was measured in bovine mammary gland biopsies
repeatedly collected at different stages of the pregnancy lactation cycle
(for details see [172, 173]). The mRNA expression of TRPV6 was
normalized to the mean of the two housekeepers ubiquitin and
cyclophilin. Data are presented as mean ± SD. Statistical analysis was
performed using Kruskal-Wallis ANOVA followed by Dunn’s Multiple
Comparison Test. Day −48 and −16: dry period, non-lactating state; day
14, 42, 88, 172, −77: early, mid and late lactation
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[6] as calcium phosphate, calcium citrate and calcium com-
plexed with caseins, the latter comprising the majority of the
total calcium present in the milk [24]. The transporters likely
to be responsible for calcium accumulation in the Golgi retic-
ulum are the newly discovered secretory pathway Ca2+-
ATPases (SPCAs; [25, 26]). Two SPCA isoforms, termed
SPCA1 and SPCA2, have been reported to exist in humans
and also to be localized in the Golgi complexes [27–29].
SPCA1 is ubiquitously expressed, including its presence in
the mammary gland [27], and is thought to represent a house-
keeping form of the pump important for calcium homeostasis
in the lumen of the Golgi. SPCA2 has a more restricted tissue
distribution and the mammary gland is one of the tissues
where it is predominately found [28]. Our knowledge about
the exact role of SPCAs in the mammary gland is still limited.
Experimental evidence supports the idea that regulation of
SPCA2 is related to milk production and/or secretion as it
has been observed that mRNA levels of SPCA2 increase 35-
fold (at day 1 of lactation) compared to nulliparous mice [30].
In contrast, SPCA1 displays a modest increase in its expres-
sion being ~1.5-fold at day 10 during pregnancy and ~2-fold
at day 1 of lactation in mice [30] and up to 6-fold in lactating
rat mammary gland [31]. Besides calcium transport, SPCAs
can also pump Mn2+ to the luminal Golgi. Both cations are
required for activation of intraluminal enzymes needed for
protein and carbohydrate modifications. As an example,
Ca2+ and Mn2+ stimulate casein phosphorylation by modulat-
ing casein kinase activity, Mn2+ being more effective than
Ca2+ [32]. Casein phosphorylation and its interaction with
calcium phosphate are important factors that determine the
normal casein micellar structure secreted by the mammary
gland [32, 33]. Calcium accumulation in the Golgi would then
be necessary not only for milk enrichment but also for the
organelle’s normal function [34] and could also contribute to
the maintenance of the cytosolic calcium levels low in order to
prevent calcium cytotoxicity.
Role of Calcium Pumps In addition to SPCAs, calcium uptake
into Golgi has also been attributed to sarco(endo)plasmic
reticulum Ca2+- ATPases (SERCAs) that are not restricted to
the ER and to plasma membrane Ca2+-ATPases (PMCAs) in
transit to the plasma membrane [35]. SERCAs involvement in
the mammary gland during lactation seems to be also related
to the synthesis of new secretory proteins in the ER, mainly
the caseins, but not to the extent or rate of their secretion [32].
PMCAs, however, play a more significant role in terms of
calcium secretion than SERCAs. In fact PMCA2 plays a
major role in calcium secretion (Fig. 2), since null mutations
in PMCA2 of lactating mice lead to a significant decrease
(~ 60-70 %) in the calcium content in the milk [22, 36].
Among the human PMCAs isoforms (PMCA1-4), isoform 2
is the one that displays the highest basal activity levels and the
greatest affinity for calmodulin, which is one of the main
activators of the pump [37]. Due to its localization at the
apical membrane [22], PMCA2 transports calcium directly
into milk, independently of its putative contribution to the
Golgi accumulation. Interestingly, during lactation total
PMCA protein expression is up-regulated in rat whole mam-
mary gland due to an increase predominantly in the
PMCA2bw splice variant, which remains elevated at levels
that are almost 100-fold higher compared to levels during
pregnancy [31, 38].
These data suggest a role for PMCA2 beyond the fine
tuning of calcium signals and the maintenance of low resting
cytosolic calcium concentrations traditionally attributed to all
PMCAs [39]. Interestingly, PMCA2 has been found in secret-
ed milk particularly concentrated in milk fat globule mem-
branes derived from the apical membrane of MECs [31]. This
observation would explain the high expression of PMCA2
mRNA found in the mammary gland as a mechanism to
rapidly replace PMCA2 lost to milk secretion. In addition,
PMCA2 may also contribute to calcium accumulation in the
Golgi complex during its transit to the plasma membrane, and
as a consequence a further contribution to calcium secretion
into milk. However, PMCA2 could not been found in Golgi or
secretory vesicle membranes in immunoelectron micrographs
[22], indicating that PMCA2 in transit to the apical membrane
would not be a significant source of Golgi Ca2+-ATPase
activity.
Intracellular Calcium Buffers While transporting high fluxes
of calcium during lactation, MECs also maintain cytosolic
calcium levels low as calcium also acts as a second messenger
able to trigger a plethora of cell responses including cell death
and apoptosis [40]. In this regard, intracellular calcium
buffers, either cytosolic or intraorganelle, play a major role
[41, 42], and in some cases they also participate, although in
an indirect way, in the transepithelial transport process. For
example, calreticulin is a major calcium binding protein found
in the ER [43] that has been reported to be upregulated in the
rat mammary gland during lactation increasing the calcium
accumulation capacity of the ER needed for milk production.
Another intraorganelle calcium buffer is nucleobindin, which
is located in the Golgi apparatus and facilitates the storage of
calcium in its lumen [44, 45]. It has been observed that
overexpression of SPCA1 increases nucleobindin expression
in COS-7 cells [36]. Thus, increasing the expression of
intraorganelle calcium buffer proteins assist both maintaining
low cytosolic calcium concentrations and in calcium uptake
into the vesicles prior to the release of their content at the
apical surface.
In summary, calcium secretion into the milk is the result of
the concerted mechanisms of its uptake into theMEC from the
blood side and its export through the apical side of the MEC.
Although there is substantial evidence for the involvement of
different channels and pumps in calcium enrichment of the
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milk during lactation, more experimental efforts are required
to elucidate the exact molecular events. Currently, the identity
of the calcium channel that mediates transport of calcium
across the basolateral membrane of the MEC is unknown.
Moreover, there is no consensus on the mechanism responsi-
ble for its secretion into the alveolar lumen: one model pro-
poses that most or all of the calcium in the milk is likely
derived from exocytotic secretory vesicles from the Golgi
compartment while another model claims that the active apical
transport mediated by Ca2+-ATPases (PMCAs) is of central
importance. These two mechanisms may not be mutually
exclusive, and the contribution of each of them to calcium
secretion needs to be carefully examined.
Role of Calcium Transporters in Breast Cancer Intracellular
Ca2+ signaling is a key regulator of proliferation, cell cycle
progression and apoptosis. There is increasing evidence that
PMCA alterations together with an increase in Ca2+ influx
mediated by some members of the TRP family of calcium
channels are associated with the development and/or progres-
sion of breast tumors [16, 46–48]. The up-regulation of
PMCA2 and the down-regulation of PMCA4 observed in
the rat mammary gland during lactation appears to be involved
in regulating differentiation and proliferation processes in this
tissue [38]. Mammary gland involution upon weaning is trig-
gered by milk stasis [49] which is associated with PMCA2
down-regulation. By decreasing PMCA2 expression, the al-
veoli undergo a sustained increase in intracellular calcium
levels and as a consequence apoptosis [50], thus providing a
mechanism of coupling the secretory process of lactation with
the cell death machinery required for involution.
Pathophysiological PMCA2 activity may lead to mammary
gland tumorigenesis and protection of breast cancer cells by
preventing them from apoptosis. This may explain why ele-
vated PMCA2 expression is associated with larger tumors,
higher grade and nodal metastases, and prediction of poor
outcome in breast cancer patients [50].
Overexpression of TRPV6 has been furthermore associated
with breast cancer and mammary cell proliferation. TRPV6 is
up-regulated in breast cancer tissue compared with normal
mammary tissue, both at the protein [16] and mRNA [46]
level. An increase in the transcription of TRPV6 up to 69 %
was observed when T47D breast cancer cells were treated
with estrogen and progesterone. [46]. Moreover, blocking
the estrogen receptor with tamoxifen caused a reduction of
TRPV6 transcript levels. Interestingly, tamoxifen not only
down-regulated TRPV6 mRNA expression, but also directly
inhibited TRPV6 calcium channel activity with an IC50 value
of 7.5 μM [46]. Based on to these results, it was suggested
that the inhibition of TRPV6 accounts, at least in part,
for the antiproliferative activity of the widely used breast
cancer drug treatment tamoxifen. In T47D cells, TRPV6
silencing reduced the proliferation rate by 60% with a
concomitant reduction of calcium transport by 50 % [46]. In
agreement, recent studies have shown that higher levels of
TRPV6 are correlated with more invasive breast cancers [48]
and that breast cancer patients with high TRPV6 levels have
decreased survival rate compared with patients to low or
intermediate TRPV6 expression [51]. Specific TRPV6 inhib-
itors might be clinically useful for the treatment of estrogen
receptor-negative breast cancers.
Although the observations on PMCA2 and TRPV6 seem to
conflict each other, as in both cases the resulting phenotype
(up-regulation of a calcium pump or up-regulation of a calci-
um channel) appears to provide an advantage in survival to the
cancer cell, it may be possible that in the first case the higher
calcium efflux confers cell resistance to apoptosis while in the
second case, the higher calcium influx provides an augmented
response to proliferative signals. Thus, further studies on the
role of calcium transport pathways in breast cancer develop-
ment and progression are needed.
Trace Element Transport into Milk
Adequate supply of trace elements, such as zinc, copper and
iron, from breast milk is essential for optimal neonatal growth
and development. The concentration of these trace elements in
breast milk is tightly regulated and maintained by MECs
during lactation. This regulatory activity is particularly nota-
ble in two different aspects:
1. The concentration of trace elements in breast milk are
remarkably stable at each of the different stages of lacta-
tion [52]. Independent of the absolute values, the concen-
trations of iron [53–55], copper [55, 56] and zinc [55, 57]
in human milk are highest during the first few days after
birth and subsequently decrease as lactation progresses.
2. Milk levels of these trace elements are independent of
maternal mineral status [58, 59]. There is no significant
correlation between maternal intake of cooper, iron, and
zinc and the corresponding trace element levels in human
milk [54, 60].
The current experimental evidence suggests that the secre-
tion of iron, zinc, and copper into milk is therefore tightly
regulated by MECs. Despite their importance regarding the
nutritional aspects of milk, there is only scarce information
available about the molecular and cellular mechanisms regu-
lating trace element concentrations in the milk.
Iron Transport in the Mammary Gland
The concentration of iron in breast milk is relatively low
compared to the calculated requirements for the growing
J Mammary Gland Biol Neoplasia (2014) 19:73–90 79
infant. Due to extensive iron stores present at birth full term
infants only become vulnerable to iron deficiency after about
6 months of age [61, 62]. Nonetheless, the mammary gland
has a remarkable capacity for controlling breast milk iron
levels within a narrow concentration range. Moreover, iron
bioavailability in human milk is higher than in cow’s and
formulas [63], suggesting that breast milk supply is important
to meet the iron needs of breast-fed infants. Importantly,
maintaining breast feeding for at least 6 months has been
recommended to prevent iron deficiency in infants [61, 62].
Therefore, understanding the transport mechanisms involved
in iron secretion into milk is important to understand the role
of this trace mineral in infant nutrition.
Epithelial Iron Uptake Pathway Cellular iron uptake is a
complex process that is coordinately regulated by several
proteins, such as transferrin, transferrin receptor and divalent
metal transporter-1 (DMT1; SLC11A2). Most cellular iron is
acquired from holotransferrin (i.e. diferric transferrin). Iron in
serum is chelated by transferrin and transported to the different
tissues for utilization and storage. At the extracellular fluid
pH, holotransferrin binds with high affinity to a transferrin
receptor-1 (TfR) in the plasma membrane causing its internal-
ization. After endocytosis, the endosome is acidified causing
the dissociation of iron from transferrin-TfR complex. The
apotransferrin-TfR complex is recycled to the cell surface,
where it is again exposed to the extracellular fluid. The phys-
iological extracellular pH prompts the dissociation of trans-
ferrin from its receptor.
Ferric iron released from the transferrin-receptor complex
into the endosomes is reduced to the ferrous form bymembers
of the six-transmembrane epithelial antigen of the prostate
(STEAP) family [64–66]. Iron is subsequently transported
out of the endosome to the cytosol by DMT1 [67–70]. This
transporter uses the H+ electrochemical gradient as the driving
force to transport a rather broad range of divalent metal ions,
such as Fe2+, Mn2+ and Zn2+ [71, 72]. In addition to DMT1,
other transporters and ion channels, such as zinc transporters
of the SLC39A family [73–75] and calcium ion channels
[76–78] have been shown to mediate iron uptake. However
their physiological role remains largely unknown. Once in the
cytosol most intracellular iron binds to ferritin, the major
storage form of iron. A small pool of soluble iron is main-
tained as a component of many cellular functions, such as
energy transduction by mitochondrial cytochromes.
Iron is transferred from rat plasma tomilk in a rapid process
that does not involve cellular iron pools [79, 80]. Iron uptake
by the MECs is mediated by TfR and it has been proposed to
be the initial rate-limiting step in the transfer of iron into milk
[81]. TfR-mediated iron uptake in MECs has been described
in rabbit [82], rat [83, 84] and mouse [81, 85]. However the
role of TfR in iron transport in the lactating mammary epithe-
lium remains unclear. In contrast to milk iron levels that have
been shown to decrease during lactation, a significant increase
in TfR occurs during mammary growth and the TfR level
remains high during lactation in rat [84, 86] and mouse [85]. It
was suggested that the control of milk iron concentration
occurs following iron uptake into the mammary gland [87].
The transport of iron into the cytosol of MECs is mediated
by DMT1. This transporter has been shown to be present in
the intracellular compartment of secretory epithelial cells lin-
ing the alveolar lumen in rat mammary gland [88].
Interestingly, in rat mammary, gland DMT1 levels were
shown to decrease throughout lactation with the highest levels
observed in early lactation [88, 89]. This decrease in DMT1
expression correlates with the normal decline in milk iron
during lactation in rats [88]. In the same study, no significant
differences in DMT1 expression levels in the mammary gland
and milk iron levels were observed when comparing rats fed a
normal diet with those fed a low-iron diet [88]. These results
suggest that DMT1 expression in the mammary gland as well
as milk iron levels are independent of the dietary iron intake.
Moreover, low iron intake resulted in decreased mammary
gland iron content, suggesting that DMT1 expression in the
mammary gland is not regulated by intracellular iron levels as
it was observed in small intestine [71]. Alternative splicing
between two 5′ and two 3′ exons result in four DMT1 isoforms
[90] that differ in their tissue distribution and regulation. Only
two of them are regulated by iron on the post-transcriptional
level by the iron responsive element (IRE)/iron regulatory
protein (IRP) system (see [91] for review). The decline of
DMT1 expression with an unchanged mammary gland iron
concentration throughout lactation [88] suggests that the IRE/
IRP system may not play a key role in regulating the normal
decline of DMT1.
The effect of a marginal vitamin A diet in rats added
another layer of complexity to the regulation of iron secretion
into milk. Marginal vitamin A deficiency reduced milk and
mammary gland iron levels which was correlated with a
decreased TfR and DMT1 expression despite having little
effect on maternal iron status [92]. However, it is unclear
whether vitamin A has a direct effect on TfR and DMT1
expression resulting in a reduction of iron levels in the milk.
Interestingly, reduced milk iron concentration due to marginal
maternal vitamin A intake in rats resulted in severe iron
deficiency anaemia in the suckling neonate [92]. Pregnant
and lactating woman are especially vulnerable to iron defi-
ciency anemia caused by vitamin A deficiency. Maternal
anemia adversely affects the iron status including iron stores
of the newborns [93, 94], increasing the risk for iron deficien-
cy, if iron intake is inadequate. Iron milk levels may be
particularly important to meet the iron needs of neonates with
decreased iron stores.
Iron Transport Within the Cell The vectorial transepithelial
transport of iron requires its intracellular translocation across
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the cytosol of the epithelial cell. Low molecular weight che-
lates or chaperone proteins were suggested to regulate the
transport of iron within the cell. Paraferrin, a large-
molecular-weight protein complex, has been postulated to
shuttle iron within human and rat enterocytes [95]. The poly
r C-binding protein (PCBP) 1 acts as a cytosolic iron chaper-
one that facilitates the loading of iron into ferritin [96].
However, the molecular mechanisms involved in iron transfer
from apical to basolateral membranes within epithelial cells,
such as MECs, remains largely unknown.
Epithelial Iron Efflux Pathway Ferroportin-1 (FPN, also
known as Ireg 1 or MTP1), the product of the SLC40A1 gene,
is the only known mechanism that mediates the transport of
iron out of the cell and it appears to be present in almost all cell
types. It is expressed at particularly high levels in several
tissues and cells that play critical roles in body iron homeo-
stasis including duodenal enterocytes, placenta
syncytiotrophoblasts, hepatocytes and reticuloendothelial
macrophages. The localization of FPN in cells and tissues is
consistent with its proposed function of exporting iron from
cells. The duodenal expression of FPN is limited to the
basolateral membrane of enterocytes, particularly at the tip
of the villous rather than the crypt [97–99]. FPN is also
expressed at the basal surface of placental syncytiotrophoblasts,
where the protein is thought to be involved in iron transfer
between the maternal and fetal circulation [98]. FPN is
highly expressed in macrophages, particularly those resi-
dents in the red pulp of the spleen, bone marrow, and the
Kupffer cells of the liver. In these cells, iron released
during the degradation of damaged or senescent erythro-
cytes is transported out of the cell by FPN. This erythroid/
marcrophage recycling system is responsible for approxi-
mately 80 % of daily iron traffic in the body.
The cellular iron efflux transporter FPN has been shown to
be expressed in human [100] and rat mammary gland [88].
Within rat MECs, FPN has been shown to be localized at both
intracellular- and membrane-associated compartments [92].
According to its intracellular localization in rat MEC, it was
suggested that FPN may be involved in the transport of iron
into the Golgi and secretory vesicles [88]. This model pro-
poses that iron is concentrated in the Golgi and secretory
vesicles and secreted by exocytosis. MECs seem to have an
efficient mechanism for transporting iron into vesicles of the
ER-Golgi secretory pathway. Iron is present in the lipid frac-
tion of the milk complexed with the enzyme xanthine oxidase
as well as in the aqueous fraction mainly associated with milk
proteins, such as casein and lactoferrin [63, 101]. Similarly to
MECs, FPN is predominantly localized to a cytoplasmic
compartment in reticuloendothelial system cells [97, 102,
103], were it was proposed to mediate iron transport from
the cytosol to an intracellular vesicular compartment [97,
103]. Although the role of FPN in the transport of iron
across the plasma membrane is well established, its role in iron
trafficking between the cytosol and organelles remains specu-
lative. FPN localized at the plasmamembranemay alsomediate
a direct secretion of iron into the milk across the apical mem-
brane. Direct iron export by FPN through the plasmamembrane
of macrophages has also been suggested [102]. Confocal fluo-
rescent analysis revealed the presence of FPN microdomains at
the plasma membrane of bone marrow derived macrophages,
suggesting a vesicular trafficking of the protein between the
cytosol and cell surface [103]. Alternatively to its putative role
as an intravesicular iron “concentrator”, FPN expressed at the
intracellular vesicular compartment may be recruited to the
membrane when needed for iron export.
The regulation of FPN expression seems to be a complex
process that may involve several different regulatory mecha-
nisms in a tissue-specific manner. Originally, FPN expression
in murine liver and duodenum was shown to be regulated by
iron in a reciprocal manner [97]. In Kupffer cells of the liver,
FPN protein levels correlate directly with iron levels [97]. This
pattern of regulation has also been shown in HepG2 cells
[104] and macrophages [105, 106]. In contrast, duodenal
epithelial cells show a strong FPN immunohistochemical
staining in iron-deprived mice and weaker staining in iron-
repleted mice [97]. Duodenal FPN expression has also been
shown to be upregulated by iron deficiency or downregulated
by iron excess in humans [107], mice [99] and rats [108]. In
mouse placental syncytiotrophoblasts no changes in the expres-
sion of FPN were observed after iron depletion [109]. Although
iron concentration remains unchanged throughout lactation in rat
mammary gland, FPN expression is higher during early lactation
and decreases throughout lactation [88]. The regulation of FPN
expression by iron is currently poorly understood. FPN tran-
scripts containing IRE and non-IRE have been reported. An
mRNA encoding FPN that contains IRE in the 5′ UTR [97]
could be regulated by iron at the post-transcriptional level by the
IRE/IRP system. FPN transcripts that are not subject to repres-
sion by the IRE/IRP system in iron-deficient conditions have
been described in duodenal enterocytes and in erythroid cells
[110, 111]. Similarly to DMT1, the IRE/IRP system may not
play a role in regulating the normal decline of FPN expression in
mammary gland during lactation. The mechanisms regulating
the decline in mammary gland FPN throughout lactation are not
known.
At the post-translational level, FPN expression is reg-
ulated by ubiquitylation through its interaction with
hepcidin (HEP). The peptide hormone HEP is secreted
mainly by the liver in response to inflammation, hypoxia
and changes in body iron stores levels [112]. HEP acts as
a negative regulator of the iron export to the plasma, as it
binds the iron exporter FPN and induces its internaliza-
tion and degradation [113]. The FPN-HEP regulatory axis
has been shown to be present and functional in human
MECs. Pro-HEP and HEP were detected in human
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MECs [100, 114] and HEP-mediated degradation of FPN in
these cells was associated with an increase in ferritin levels
and an elevated labile iron pool [100]. HEP and its precursor
pro-HEP has been shown to be secreted into milk [114]. It is
unknown whether the milk peptides originate in the mammary
gland tissue or are transported from the plasma. Moreover, the
role of the FPN-HEP regulatory axis in the MECs remains
largely unknown.
Oxidation of Iron at the Apical Membrane Iron oxidation in
the extracellular compartment seems to be essential for its
transport out of the cell by FPN. Ceruloplasmin (CP) plays
an essential role in mammalian iron homeostasis as the
major multicooper ferroxidase in blood. Absence of
multicopper oxidases, such as CP, leads to cellular iron
retention due to an ubiquitin-mediated FPN internalization
and degradation [115]. A marked impairment in iron efflux
was observed in reticuloendothelial cells and hepatocytes
of CP-null mice suggesting that this multicopper oxidase
plays a vital role in the movement of iron out of these cells
[116]. However, it is unclear if CP is the only ferroxidase
involved in iron release from body stores since patients
with aceruloplasminemia [117] and CP-null mice [116]
present moderate anemia. In enterocytes, FPN-mediated
efflux of Fe2+ is coupled to its oxidation by hephaestin, a
transmembrane-bound CP homologue [118–120]. Milk CP
is specifically synthetized by the mammary gland and
secreted into milk [121–123]. Zyklopen, a membrane
bound protein of the multicooper ferrioxidase family with
high sequence identity to hephaestin and CP, was found to
be present in mouse mammary tissue and, in MCF7 and
T47D cells [124]. Interestingly, casein was shown to oxi-
dize Fe2+ and the resulting Fe3+ is complexed to this
protein [125]. However, the precise mechanism by which
iron transported out of the cytosol by FPN and whether
zyklopen is required for this process still remains elusive.
Figure 3 shows a representation of the proposed mecha-
nisms that regulate the iron concentration in milk.
Holotransferrin in the circulation is taken up by the TfR at
the basal side of MECs. The transferrin-TfR complex is
endocytosed into a low pH endosomal compartment where
iron is released from transferrin. Iron is likely oxidized in the
endosomal compartment by a ferroxidase of the STEAP
family and then transported out from the endosome to the
cytoplasm via DMT1. Once in the cytosol, iron may be
utilized by MECs because lactation is an energy-expensive
process or transferred through the cytoplasm for its secretion
into milk by an unknown mechanism. Finally, iron may be
transported into the Golgi and/or secretory compartment,
where it can then bind to iron-binding proteins, and is secreted
by exocytosis. Iron in the cytoplasm may also be utilized in
the synthesis of iron-containing enzymes, such as xanthine
oxidase, which are secreted with the milk fat globule.
Copper Transport in the Mammary Gland
Cooper concentration in milk is 3 to 4 times lower than serum
[126] indicating that its secretion into milk is regulated by the
mammary gland. The newborn have ample stores of copper in
the liver, even 10 times higher than adult levels, that could be
mobilized during early life [63]. However, neonates with poor
liver copper stores (e.g. premature human infants) are more
Fig. 3 Iron transport in mammary epithelial cells. Iron is acquired by the
MEC from holotransferrin trough a TfR-mediated process at the basolateral
membrane. After endocytosis, the endosome is acidified by a V-ATPase H+
pump causing the dissociation of iron from the transferrin-TfR complex.
Thereafter, iron is transported out of the endosome to the cytosol by the H+-
coupled transporter DMT1 (SLC31A2). Once in the cytosol most intracel-
lular iron binds to ferritin, the major storage form of iron. A small pool of
soluble iron is maintained for many cellular functions, such as energy
transduction by mitochondrial cytochromes. Ferroportin-1 (SLC40A1) is
the only known transport mechanism that mediates cellular iron efflux. Iron
can be transported out of the cell directly into the milk by FPN. Alterna-
tively, it was suggested that FPN may be involved in the intracellular
trafficking of iron between the cytosol and organelles. In this model, iron
is finally secreted into milk by exocytosis of secretory vesicles at the apical
membrane. The molecular entity that mediates iron oxidation after its
transport by FPN remains unknown
82 J Mammary Gland Biol Neoplasia (2014) 19:73–90
vulnerable to nutritional copper deficiency [127, 128].
Moreover, toxic-milk (tx) mice pups die in the second week
from severe copper deficiency due to low liver copper stores
and low intakes from maternal copper-deficient milk [129].
Hence, maternal milk copper may contribute significantly to
the nutritional copper status of the newborn, especially in those
with low liver copper stores such as premature human infants.
Epithelial Copper Uptake Pathway CTR1 transporter, a
member of the SLC31 family, has been found to be essential
for mammalian cellular copper uptake as Slc31a1-knockout
mice die at early gestational stage [130]. Structural studies
suggest that CTR1 assembles into a homotrimer in a channel-
like architecture that forms a membrane spanning pore
[131, 132]. The monomers are predicted to have three trans-
membrane domains with the N-terminal domain located at the
extracellular side and C-terminal domain in the cytosol.
Human CTR1 displays selectivity and high affinity for the
reduced Cu(I) form (with an apparent Km value of 1.7 μM)
when overexpressed in HEK293 cells [133]. CTR1-mediated
copper uptake has been shown to be an energy-independent
process and is stimulated by extracellular low pH and high K+
concentration. A model has been proposed to address the
mechanism of CTR1-mediated copper transport through the
plasma membrane suggesting that CTR1 acts as a membrane
transporter that mediates the transport of copper directly from
the extracellular medium to the cytosol. The N-terminal do-
main binds and facilitates the transfer of copper through the
pore channel domain [134]. Cooper circulates mainly bound
to CP and, to a lower degree, to other plasma protein carriers
and low molecular weight chelating agents. However, func-
tional and/or physical interactions between the N-terminal
domain of CTR1 and extracellular copper carriers have not
been reported so far. Moreover, the mechanisms by which
copper is reduced prior to transport through CTR1 are
unknown.
The mechanism that mediates copper uptake into the
MECs remains also largely unknown. Copper uptake into
MECs is likely mediated by CTR1, however it is unknown
how this metal is delivered to MECs from its plasma protein
carriers. This transporter has been shown to be expressed in rat
mammary gland [135, 136] both at the plasma membrane and
intracellular vesicles [135]. A greater basal mammary gland
copper uptake was observed during early lactation compared
with late lactation. Furthermore, suckling resulted in enhanced
copper transport into the mammary gland. However, mamma-
ry gland Ctr1 mRNA and protein levels were not significantly
different between early and late lactation. These results sug-
gest that the decrease observed in mammary gland copper
uptake as lactation progeses may be primarily a result of
declining copper levels in the maternal circulation [135]. In
contrast, prolactin stimulation increases copper secretion across
MECs with a concomitant increase of CTR1 plasma membrane
abundance [135], suggesting that this transporter is expressed at
the intracellular vesicular compartment and may be recruited to
the membrane when needed for copper export.
Copper Transport Within the Cell Following entry via the
CTR1, copper is delivered to several copper chaperones,
which subsequently transfer the metal to specific targets.
However, copper binding to specific chaperone proteins
seems not to be the rate-limiting step in copper acquisition
by the cell. Recently, the tripeptide glutathione has been
shown to play an important role in copper handling immedi-
ately after its transport by CTR1 [137]. Glutathione may be
involved in the transfer of copper to specific chaperone pro-
teins (for review see [138]). Copper transfer from the uptake
system to the export system is carried out by the copper
chaperone protein ATOX1 (for review see [139]). ATOX1
has been shown to be expressed in rat mammary gland
[135], however its role in copper delivery to the export system
has not been proven yet.
Epithelial Copper Efflux Pathway Copper transport out of the
cytosol across cellular membranes is mediated by two P-type
ATPases, namely ATP7A and ATP7B [139]. ATP7A and
ATP7B play major roles in cellular copper homeostasis and
their absence or malfunction leads to genetically inherited
disorders, Menkes and Wilson disease, respectively. Under
normal conditions, both proteins are predominantly located
at the trans-Golgi network of the cell mediating the delivery of
copper to the newly synthesized cuproenzymes within the
secretory pathway. High intracellular copper levels prompt
the redistribution of these proteins to different vesicular com-
partments to eliminate excess copper from the cell.
Copper delivery to the milk seems to be facilitated by both
ATP7A and ATP7B copper-ATPases. ATP7A [140] and
ATP7B [141] have been reported to be expressed in the
mammary gland. The intracellular distribution of ATP7A
and ATP7B changes during lactation. In non-lactating mam-
mary gland these proteins have tight perinuclear localization
[140, 141], consistent with the trans-Golgi network. In con-
trast, ATP7A and ATP7B show a granular diffuse cytoplasmic
pattern during lactation [140, 141]. However, ATP7A and
ATP7B seem to have different roles during lactation. The
involvement of ATP7B in copper export from the mammary
gland is evident from the phenotypes of tx and Atp7b- knock-
out mice. The tx mutation in mice results in defective mam-
mary gland ATP7B impairing copper export into milk leading
to neonatal death from copper deficiency [141]. Similar cop-
per perinatal deficiency is observed in Atp7b- knockout mice
[142]. Interestingly, some copper is being delivered into milk
even in the absence of functional ATP7B (20–30 % of nor-
mal), suggesting that an ATP7B-independent pathway partial-
ly compensates for ATP7B lack of function. ATP7B appears
to be the primary transporter mediating copper secretion into
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milk by delivering copper to CP and to secretory vesicles. The
role of ATP7A in copper secretion into milk remains unclear.
It was proposed to ATP7A could be involved in copper
delivering to CP and that this pathway may account for the
20–30 % of the remaining secretion of copper into milk in the
txmice [143, 144]. Alternatively, it was proposed that ATP7A
located at the apical membrane could export copper directly
into the milk [135]. A role of ATP7A in the removal of copper
from the mammary gland back into the circulation was also
proposed [143].
Figure 4 summarizes the main mechanisms proposed to be
involved in MECs secretion of cooper into the milk.
Transport of Water Soluble Vitamins into Milk
Water soluble vitamins (ascorbic acid, biotin, folate, cobala-
min, riboflavin, thiamin, niacin, pantothenic acid and pyridox-
ine) play critical roles in maintaining normal metabolic, ener-
gy, differentiation, and growth status of mammalian cells.
Since the mammary gland cannot synthesize vitamins, these
micronutrients must be obtained from exogenous sources.
Vitamin content in human milk is directly related to the
mother’s vitamin status [145]. Since water soluble vitamins
are not stored to a large extent in the body their concentrations
in milk are more responsive to maternal dietary intake. In
general, the quantities of these vitamins in human milk are
higher than their levels in plasma, suggesting that water sol-
uble vitamins are actively secreted into milk. However, the
regulation of water soluble vitamin levels in milk seems to be
a complex process involving several different vitamin-specific
transport systems. The concentrations of niacin, pantothenic
acid and biotin in rat milk were not decreased with low-
vitamin diet, but were increased with the high-vitaminmixture
diet [146]. On the other hand, the concentrations of thiamine,
riboflavin, pyridoxine and cobalamin were decreased with
low-vitamin diet, but were not increased with the high-
vitamin diet [146]. The folate concentration in rat milk
remained constant regardless of folate intake [146]. These
results suggest that the mammary gland has a remarkable
capacity for controlling critical levels of water soluble vita-
mins in breast milk. Numerous proteins implicated in their
intestinal absorption as well as transport into cells of systemic
tissues have been described [147] (Table 1). Although, our
understanding of the transport of water soluble vitamins has
greatly improved in recent years the transport mechanisms
involved in vitamin secretion into milk remain largely
unknown.
The multidrug transporter breast cancer resistance protein
(BCRP/ABCG2) has been proposed to mediate riboflavin
transport into milk [148]. BCRP belongs to in the superfamily
of ABC transporters and is expressed in the apical membranes
of intestine, kidney and placenta epithelia and in the hepato-
cyte bile canalicular membrane. BCRP seems to have a xeno-
biotic protective function by pumping a wide variety of en-
dogenous and exogenous compounds out of the cell.
Riboflavin (vitamin B2) plays key metabolic roles in carbo-
hydrate, amino acid, and lipid metabolism and in the conver-
sion of folic acid and vitamin B6 compounds into their active
coenzyme forms. The most important biologically active
forms of riboflavin are flavin mononucleotide and flavin
adenine dinucleotide. They act as intermediaries in the transfer
of electrons in biological oxidation–reduction reactions.
Riboflavin milk content is high in early lactation and declines
thereafter [145]. In mouse mammary gland, Abcg2 was found
to be highly expressed during late pregnancy and lactation
[149]. Abcg2 was detected primarily in the apical
Fig. 4 Copper transport in the mammary epithelial cells. The CTR1
(SLC31A1) transporter mediates the uptake of copper into the MECs.
Two P-type ATPases, namely ATP7A and ATP7B, mediate copper se-
cretion into milk. ATP7B appears to be the main regulator of copper
secretion into milk by delivery copper to ceruloplasmin and to secretory
vesicles. The role of ATP7A in copper secretion into milk remains
unclear. It was proposed that the ATP7A at the apical membrane may
directly export copper into the milk, or that it could be involved in copper
delivery to ceruloplasmin at the secretory vesicles. Finally, ATP7A locat-
ed at the basolateral membrane may serve to remove copper from the
mammary gland back into the circulation
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membrane of alveolar epithelial cells, but not in main ducts.
Since milk secretion of riboflavin was not completely
abolished in the Abcg2-knockout mice (~60 % decrease), a
second independent pathway involved in riboflavin transfer
into milk was proposed [148]. The mechanisms that mediate
basolateral riboflavin uptake in MECs are currently unknown
but, recently a novel family of mammalian riboflavin trans-
porters, RFVT/SLC52, was identified (see [150] for review).
This family is composed by three members, RFVT1
(SLC52A1), RFVT2 (SLC52A2) and RFVT3 (SLC52A3),
which are ubiquitously expressed. All of them exhibit high
affinity for riboflavin, however, the transport mechanisms are
still unclear. Interestingly, RFVT3 is expressed in the luminal
side of intestinal cells where it is thought to mediate riboflavin
absorption [151, 152]. It remains to be determined if these
proteins play a role in riboflavin secretion into milk.
A receptor mediated system for cobalamin uptake in
human mammary cells was proposed [153]. Cobalamin
is transported in plasma bound to a protein called
transcobalamin II. However, in human milk cobalamin
is bound exclusively to the glycoprotein haptocorrin
[154]. It has been shown that cultured human MECs
exhibit high affinity for the transcobalamin II/cobalamin
complex but not for free cobalamin [59]. This receptor
mediated system for cobalamin in MECs was proposed
to transport vitamin B12 into the cell. After internaliza-
tion, cobalamin is transported into the milk where it is
bound exclusively to the glycoprotein haptocorrin.
However the mechanisms that mediate the transfer of
cobalamin from transcobalamin II to haptocorrin are not
yet known.
Thiamine pyrophosphate is a coenzyme required for sev-
eral key enzymes involved in energy production from
carbohydrate and amino acid metabolism. This vitamin is
transported across the plasma membrane by two members of
the SLC19 family, ThTr1 (SLC19A2) and ThTr2 (SLC19A3)
[155]. These two proteins may have different roles in thiamine
transport across epithelia [156]. Studies in Slc19a3- and
Slc19a2-null mice indicate that ThTr2 is a main regulator of
intestinal thiamine absorption [157]. The expression of the
thiamine transporter ThTr2, but not ThTr1, has been reported
to be regulated by the hypoxia inducible factor-1α in the
breast cancer cell line model BT474 [158]. However, the
expression of transporters from the SLC19 family in mamma-
ry gland has not yet been reported. Moreover, there is no
information available about the transport mechanisms that
mediate the secretion of thiamine into milk. Thiamine con-
centration in milk increases up to 10-fold during lactation
[145]. Importantly, thiamine levels in breast milk are directly
influenced by the maternal thiamine status. Maternal supple-
mentation increases thiamine milk levels to a certain extent
indicating that there is a limit in the amount that can be
transferred into milk [52].
To our knowledge, there is no information available about
the transport mechanisms involved in the secretion of ascorbic
acid, biotin, folate, niacin, pantothenic acid and pyridoxine
into the milk. Several transporters of the SLC family have
been shown to mediate cellular transport of these vitamins
(Table 1). SMVT (SLC5A6) is a widely distributed Na+-de-
pendent cotransporter that mediates the uptake of pantothenic
acid and biotin [159, 160]. SMCT1 (SLC5A8) is a Na+-
coupled monocarboxylate cotransporter widely expressed in
the body that mediates the transport of nicotinate among other
substrates [161–163]. SVCT1 (SLC23A1) and SVCT2
(SLC23A2) mediate specifically the transport of ascorbic acid
in a Na+-dependent cotransport mechanism [164–167].
Table 1 List of transporters
known to be involved in the
transport of water soluble
vitamins
a Values of milk water soluble vi-
tamins concentrations were taken
from [52, 145, 174]
Vitamin Milk concentrationa Transporter family
SLC ABC
Thiamine (B1) 200 μg/L SLC19A2 (ThTr1)
SLC19A3 (ThTr2)
Riboflavin (B2) 350–500 μg/L SLC52A1 (RFVT1)
SLC52A2 (RFVT2)
SLC52A3 (RFVT3)
ABCG2 (BCRP)
Niacin (B3) 1–2 mg/L SLC5A8 (SMCT1)
Pantothenic acid (B5) 2–10 μg/L SLC5A6 (SMVT)
Pyridoxine (B6) 50–250 μg/L unknown
Biotin (B7) 10–25 μg/L SLC5A6 (SMVT)
Folate (B9) 80–100 μg/L SLC46A1 (PCFT)
SLC19A1 (RFC)
ABCC1-4 (MRP1–4)
Cobalamin (B12) 0.3–3.2 μg/L unknown ABCC1 (MRP1)
Ascorbic acid (C) 50–60 mg/L SLC23A1 (SVCT1)
SLC23A2 (SVCT2)
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Folate has been shown to be transported by several members
of the SLC and ABC transporter families (for review see [155,
168, 169]). RFC (SLC19A1) is an organic anion antiporter that
mediates the delivery of folate to systemic tissues at neutral
pH. PCFT (SLC46A1) transports folic acid and reduced folates
with high affinity at low pH (optimal pH=5.0–5.5). Many
organic anion facilitative transporters from the SLC21 family
have also been shown to transport folates. Cellular efflux of
folates is mediated by multidrug resistance associated proteins
(ABCC/MRP) MRP1–4, which belong to the ATP-binding
cassette superfamily (reviewed in [170, 171]). Characterizing
the expression and the role of these transporters in MECs will
be essential to improve our understanding of water soluble
vitamin secretion into milk.
Concluding Remarks
The mammary gland has a unique capacity to tightly regulate
milk secretion of macro and micro nutrients and thereby
protect the offspring from maternal deficiency or excess of
these elements while facing the challenge of maintaining its
own homeostasis. The secretion of milk nutrients by MECs is
a complex process that involves the orchestration of several
transport mechanisms located at their apical and basolateral
membranes. Over the past decade, substantial progress has
been made in the understanding of transport mechanisms that
regulate the concentration of milk nutrients. Several trans-
porters of the ABC and SLC superfamilies play a major role
in milk nutrient secretion. However, several important ques-
tions remain to be addressed.
Much effort is required in the field of calcium secretion into
milk as the mechanism of calcium entry remains unclear and
there is no consensus in the model of calcium secretion
(e.g. Golgi pathway versus apical active transport). Extensive
research in the field of MECs transport mechanisms is required
for a deeper understanding of the role of calcium transporters in
the development and progression of breast cancer diseases in
order to provide novel therapeutic strategies.
Moreover, further characterization and a better understand-
ing of the transport mechanisms involved in micronutrient
secretion into milk is needed. The exact role of TfR, DMT1
and FPN in iron secretion into milk and the regulation of iron
uptake by the MECs remain largely unknown. Whether the
IRE or the non-IRE DMT1 and FPN variants are the predom-
inant forms present in the mammary gland needs to be inves-
tigated. Since lactation is an energy-expensive process, it
cannot be excluded that the expression of these proteins in
the mammary gland during lactation may simply reflect an
increased metabolic demand for iron to be utilized for exam-
ple by the oxidative phosphorylation cytochrome system. If
this is the case, further work is needed to identify the
transport mechanisms that regulate iron secretion into
milk. In particular, the transport mechanisms that medi-
ate copper uptake in MECs and the secretion of water
soluble vitamins into milk remain to be elucidated.
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